Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to trichostatin A and 1α,25-dihydroxyvitamin D3

Nucleic Acids Research

Volumn 36, Issue 1, 2008, Pages 121-132

  Malinen, Marjo ^a   Saramäki, Anna ^a   Ropponen, Antti ^a   Degenhardt, Tatjana ^a   Väisänen, Sami ^a   Carlberg, Carsten ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2C; CYCLIN DEPENDENT KINASE INHIBITOR 2D; HISTONE DEACETYLASE; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE INHIBITOR; RNA; TRICHOSTATIN A; VITAMIN D RECEPTOR;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME INDUCTION; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ACETYLATION; ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; CALCITRIOL; CELL LINE; CELL LINE, TUMOR; CHROMATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, CALCITRIOL; REPRESSOR PROTEINS; RNA INTERFERENCE; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

EID: 38349142775     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm913     Document Type: Article

References (35)

1. Minucci,S. and Pelicci,P.G. (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer, 6, 38-51.
2. Marks,P.A., Miller,T. and Richon,V.M. (2003) Histone deacetylases. Curr. Opin. Pharmacol., 3, 344-351.
3. Gallinari,P., Di Marco,S., Jones,P., Pallaoro,M. and Steinkühler,C. (2007) HDACs, histone deacetylation and gene transcription: From molecular biology to cancer therapeutics. Cell. Res., 17, 195-211.
4. Codina,A., Love,J.D., Li,Y., Lazar,M.A., Neuhaus,D. and Schwabe,J.W. (2005) Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors. Proc. Natl Acad. Sci. USA, 102, 6009-6014.
5. Verdin,E., Dequiedt,F. and Kasler,H.G. (2003) Class II histone deacetylases: Versatile regulators. Trends Genet., 19, 286-293.
6. Dequiedt,F., Kasler,H., Fischle,W., Kiermer,V., Weinstein,M., Herndier,B.G. and Verdin,E. (2003) HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity, 18, 687-698.
7. Kawaguchi,Y., Kovacs,J.J., McLaurin,A., Vance,J.M., Ito,A. and Yao,T.P. (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell, 115 727-738.
8. Monneret,C. (2005) Histone deacetylase inhibitors. Eur. J. Med. Chem. 40, 1-13.
9. WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells. Biochem. Biophys. Res. Commun., 324, 860-867.
10. WAF1 involves changes ii promoter-associated proteins, including HDAC1. Proc. Natl Acad. Sci. USA, 101, 1241-1246.
11. Yokota,T., Matsuzaki,Y., Miyazawa,K., Zindy,F., Roussel,M.F. and Sakai,T. (2004) Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Oncogene, 23, 5340-5349.
12. INK4c gene: Differential activation and cooperation with p19INK4d gene. FEBS Lett., 574, 171-175.
13. WAF1 expression and gene-associated histone acetylation. Proc. Natl Acad. Sci. USA, 97, 10014-10019.
14. Malumbres,M. and Barbacid,M. (2007) Cell cycle kinases in cancer. Curr. Opin. Genet. Dev., 17, 60-65.
15. INK4B/MTS2 - related CDK6 inhibitor, correlates with wild-type pRb function. Genes. Dev., 8, 2939-2952.
16. Hirai,H., Roussel,M.F., Kato,J.-Y., Asbmun,R.A. and Sherr,C.J. (1995) Novel INK4 proteins, p18 and p19, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15, 2672-2681.
17. 3 receptor. Nucleic Acids Res., 34, 543-554.
18. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes. Dev., 10, 142-153.
19. Kip1 puzzle. Cell, 128, 241-244.
20. 3 receptor-corepressor partnership. FASEB J., 14, 1455-1463.
21. Sutton,A.L. and MacDonald,P.N. (2003) Vitamin D: More than a "bone-a-fide" hormone. Mol. Endocrinol., 17, 777-791.
22. 3 and its analogs on growth control and tumorigenesis. Front Biosci., 6, D820-D848.
23. Rachez,C., Lemon,B.D., Suldan,Z., Bromleigh,V., Gamble,M., Näär,A.M., Erdjument-Bromage,H., Tempst,P. and Freedman,L.P. (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature, 398, 824-828.
24. Jiang,H., Lin,J., Su,Z.-z., Collart,F.R., Huberman,E. and Fisher,P.B. (1994) Induction of differentiation in human promyelotic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9, 3397-3406.
25. Warrener,R., Beamish,H., Burgess,A., Waterhouse,N.J., Giles,N., Fairlie,D. and Gabrielli,B. (2003) Tumor cell-setective cytotoxicity by targeting cell cycle checkpoints. FASEB J., 17, 1550-1552.
26. Vigushin,D.M., Ali,S., Pace,P.E., Mirsaidi,N., Ito,K., Adcock,I. and Coombes,R.C. (2001) Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin. Cancer Res., 7, 971-976.
27. 3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. J. Steroid Biochem. Mol. Biol. 89-90, 245-249.
28. Strahl,B.D. and Allis,C.D. (2000) The language of covalent histone modifications. Nature, 403, 41-45.
29. (WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells. J. Endocrinol., 179 41-53.
30. waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. J. Cell. Biochem., 73 291-302.
31. Aoyagi,S. and Archer,T.K. (2007) Dynamic histone acetylation/ deacetylation with progesterone receptor-mediated transcription. Mol. Endocrinol., 21, 843-856.
32. Ishizuka,T. and Lazar,M.A. (2003) The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol. Cell. Biol., 23, 5122-5131.
33. Franco,P.J., Li,G. and Wei,L.N. (2003) Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase. Mol. Cell. Endocrinol., 206, 1-12.
34. Metivier,R., Penot,G., Hubner,M.R., Reid,G., Brand,H., Kos,M. and Gannon,F. (2003) Estrogen receptor a directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 115, 751-763.
35. Banwell,C.M., MacCartney,D.P., Guy,M., Miles,A.E., Uskokovic,M.R., Mansi,J., Stewart,P.M., O'Neill,L.P., Turner,B.M. et al. (2006) Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin. Cancer Res., 12, 2004-2013.